by Cancer Research UK Credit: Unsplash/CC0 Public Domain A new study has shown that giving aromatase inhibitors instead of tamoxifen to premenopausal women with estrogen receptor positive (hormone-sensitive) breast cancer significantly reduces the risk of breast cancer recurrence. The results have been published today in The Lancet Oncology. For women with hormone-sensitive, operable breast cancer, giving...
